Literature DB >> 9744860

DNA damage activates p53 through a phosphorylation-acetylation cascade.

K Sakaguchi1, J E Herrera, S Saito, T Miki, M Bustin, A Vassilev, C W Anderson, E Appella.   

Abstract

Activation of p53-mediated transcription is a critical cellular response to DNA damage. p53 stability and site-specific DNA-binding activity and, therefore, transcriptional activity, are modulated by post-translational modifications including phosphorylation and acetylation. Here we show that p53 is acetylated in vitro at separate sites by two different histone acetyltransferases (HATs), the coactivators p300 and PCAF. p300 acetylates Lys-382 in the carboxy-terminal region of p53, whereas PCAF acetylates Lys-320 in the nuclear localization signal. Acetylations at either site enhance sequence-specific DNA binding. Using a polyclonal antisera specific for p53 that is phosphorylated or acetylated at specific residues, we show that Lys-382 of human p53 becomes acetylated and Ser-33 and Ser-37 become phosphorylated in vivo after exposing cells to UV light or ionizing radiation. In vitro, amino-terminal p53 peptides phosphorylated at Ser-33 and/or at Ser-37 differentially inhibited p53 acetylation by each HAT. These results suggest that DNA damage enhances p53 activity as a transcription factor in part through carboxy-terminal acetylation that, in turn, is directed by amino-terminal phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9744860      PMCID: PMC317174          DOI: 10.1101/gad.12.18.2831

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  49 in total

1.  Regulation of the specific DNA binding function of p53.

Authors:  T R Hupp; D W Meek; C A Midgley; D P Lane
Journal:  Cell       Date:  1992-11-27       Impact factor: 41.582

2.  Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases.

Authors:  I Takenaka; F Morin; B R Seizinger; N Kley
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

3.  Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases.

Authors:  Y Wang; C Prives
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

4.  Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene.

Authors:  T Juven; Y Barak; A Zauberman; D L George; M Oren
Journal:  Oncogene       Date:  1993-12       Impact factor: 9.867

5.  Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells.

Authors:  K K Khanna; M F Lavin
Journal:  Oncogene       Date:  1993-12       Impact factor: 9.867

6.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

7.  The p53-mdm-2 autoregulatory feedback loop.

Authors:  X Wu; J H Bayle; D Olson; A J Levine
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

8.  p53 domains: identification and characterization of two autonomous DNA-binding regions.

Authors:  Y Wang; M Reed; P Wang; J E Stenger; G Mayr; M E Anderson; J F Schwedes; P Tegtmeyer
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

9.  Specific sequences from the carboxyl terminus of human p53 gene product form anti-parallel tetramers in solution.

Authors:  H Sakamoto; M S Lewis; H Kodama; E Appella; K Sakaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

10.  p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNK1.

Authors:  D M Milne; L E Campbell; D G Campbell; D W Meek
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

View more
  395 in total

1.  Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage.

Authors:  N H Chehab; A Malikzay; E S Stavridi; T D Halazonetis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.

Authors:  A Ito; C H Lai; X Zhao; S Saito; M H Hamilton; E Appella; T P Yao
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

3.  Acetylation of TAF(I)68, a subunit of TIF-IB/SL1, activates RNA polymerase I transcription.

Authors:  V Muth; S Nadaud; I Grummt; R Voit
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

Review 4.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

5.  Stress signals utilize multiple pathways to stabilize p53.

Authors:  M Ashcroft; Y Taya; K H Vousden
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

6.  Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage.

Authors:  K Webley; J A Bond; C J Jones; J P Blaydes; A Craig; T Hupp; D Wynford-Thomas
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

Review 7.  Acetylation: a regulatory modification to rival phosphorylation?

Authors:  T Kouzarides
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

8.  In vitro evolution of thermostable p53 variants.

Authors:  I Matsumura; A D Ellington
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

9.  MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins.

Authors:  E Kobet; X Zeng; Y Zhu; D Keller; H Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

10.  Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.

Authors:  M S Rodriguez; J M Desterro; S Lain; D P Lane; R T Hay
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.